The Relationship between EGFR Mutations and the Clinicopathologic Features of Lung Adenocarcinomas Diagnosed by the Small Biopsies
의약학 > 내과학
김현정 , 신경철
대한결핵 및 호흡기학회
대한결핵및호흡기학회 추계학술발표초록집 2012년, 제114권 239(총1페이지)
0y909981.pdf [무료 PDF 뷰어 다운로드]
  • ※ 본 자료는 참고용 논문으로 수정 및 텍스트 복사가 되지 않습니다.
  • 구매가격
    30원 (구매자료 3% 적립)
    이메일 발송  스크랩 하기
    자료 다운로드  네이버 로그인
    Epidermal growth factor receptor (EGFR) mutation analysis is necessary and important in clinical practice. But sometimes advanced lung cancer is diagnosed by cytology or inadequate specimens for DNA extractions. This study was aimed to inves-tigate the association of EGFR mutations with clinicopathologic features in small biopsy specimens. The medical records of 359 lung adenocarcinoma patients were reviewed. All the specimens of these patients were investigated for EGFR mutations (Exon 18-21) by direct sequencing method. EGFR mutations were present in 37.6%, and the majority of them was exon 19 deletions (60.7%). The incidence of EGFR mutations was the highest in never-smoked women patients (54.6%). According to the histologic subtype, EGFR mutations were more frequently observed with acinar and lepidic components, conversely infrequently with solid and mucinous components. The protein expression of TTF-1 was also related with the frequency of EGFR mutations (45.7%). We can ascertain that incidence of EGFR mutations is associated with gender and smoking history in small biopsy specimens. Acinar and lepidic subtype of histology, even if the histology comfirmed by only small biopsies, can predict the high frequency of EGFR mutations. When the specimens are not enough for DNA extractions and re-biopsy is incapable, the clinicopathologic features can predict the EGFR mutation status carefully but it cannot replace the mutation analysis.
    사업자등록번호 220-87-87785 대표.신현웅 주소.서울시 서초구 방배로10길 18, 402호 대표전화.070-8809-9397
    개인정보책임자.박정아 통신판매업신고번호 제2017-서울서초-1765호 이메일
    copyright (c) 2009 happynlife. steel All reserved.